SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing a massive surge in retail interest and speculative volume, fueled by aggressive short-squeeze dynamics and the popular (though arguably mistaken) community narrative that the stock serves as a direct proxy for the upcoming SpaceX IPO. Investors are actively debating the potential for a parabolic short squeeze given the high short interest and social media momentum, while cautioning that the stock remains highly volatile and disconnected from current fundamentals.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Investors are closely monitoring geopolitical developments in the Middle East and shifting Federal Reserve rate expectations, which have triggered significant volatility and rotational trading across the Russell 2000. Community discussion remains heavily polarized between bulls betting on a market melt-up driven by AI and peace deal catalysts, and skeptical bears citing structural complacency and stagflationary concerns.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending heavily as investors react to a major partnership with the DTCC, which plans to integrate its tokenized securities platform with the Stellar network. Community discussion is focused on the potential for institutional-grade utility and increased transaction volume, leading to intense debates between bulls optimistic about a long-term price breakthrough and skeptics wary of potential consolidation after the recent surge.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors aggressively position themselves ahead of the critical HARMONi-3 interim progression-free survival readout anticipated this quarter. The community is focused on the potential for ivonescimab to challenge existing standards of care in lung cancer, balancing optimism around recent clinical data and BLA filing momentum against volatility driven by short interest and debates over trial design.

Vanguard Malvern Funds - Vanguard Short-Term Inflation-Protected Securities Index Fund

Vanguard Short-Term Inflation-Protected Securities ETF

Vanguard Short-Term Inflation-Protected Securities ETF is trending as investors grapple with shifting economic outlooks and the impact of inflation on fixed-income portfolios. The community is actively debating the effectiveness of inflation-protected securities as a hedge in a fluctuating rate environment.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The biotech sector, represented by the SPDR S&P Biotech ETF, is experiencing a surge in M&A activity and positive clinical data readouts, fueling investor optimism. The community is actively discussing the potential for a sector-wide re-rating, with particular focus on small-cap names with looming regulatory milestones and M&A potential.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as analysts highlight the bank's role in complex mega-deal financing and its public clash with Coinbase CEO Brian Armstrong over the CLARITY Act. Market observers are also actively debating the bank's technical Elliott Wave structure and potential acquisition appetite while monitoring its stance on rising interest rate risks.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is seeing significant bullish momentum driven by a newly announced advertising partnership with OpenAI, which has reinforced the company's position as a key player in AI-driven marketing infrastructure. The community is actively discussing a technical breakout, with many investors focusing on the company's consistent revenue growth and ability to secure major enterprise deals, fueling expectations of a broader re-rating for the stock.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing intense scrutiny as investors debate its long-term viability against surging AI-linked equities, with community sentiment deeply polarized between institutional accumulation and calls for a rotation into traditional tech. Much of the discourse currently centers on regulatory uncertainty, macro-pressures, and ongoing debates over whether the asset can decouple from Bitcoin's broader market volatility.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors focus on strong prescription volume growth for Vevye and the upcoming commercial expansion of its broader ophthalmic platform. The community is actively discussing the company's aggressive sales force recruitment, potential for high-impact drug launches, and the long-term compounding potential of its recurring revenue model.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taylor Devices (NASDAQ:TAYD) Raised to Buy at Wall Street Zen

Wall Street Zen raised shares of Taylor Devices from a "hold" rating to a "buy" rating in a research note on Saturday...

Insider Selling: Taylor Devices (NASDAQ:TAYD) Director Sells 5,000 Shares of Stock

Taylor Devices, Inc. (NASDAQ:TAYD - Get Free Report) Director Robert Michael Carey sold 5,000 shares of the business's stock in a transaction on Tuesday, April 28th. The stock was sold at an average...

Taylor Devices (NASDAQ:TAYD) Director Robert Michael Carey Sells 5,000 Shares

Taylor Devices, Inc. (NASDAQ:TAYD - Get Free Report) Director Robert Michael Carey sold 5,000 shares of Taylor Devices stock in a transaction on Tuesday, April 28th. The stock was sold at an average...

Taylor Devices (NASDAQ:TAYD) Shares Pass Below 200 Day Moving Average - Here's What Happened

Taylor Devices (NASDAQ:TAYD) Shares Pass Below Two Hundred Day Moving Average - Here's Why...

Taylor Devices' Q3 Earnings Increase Y/Y On Lower Costs

TAYD's Q3 earnings per share improve year over year, supported by lower SG&A costs and improved operating efficiency despite some margin pressure and falling long-term project revenue. 

Taylor Devices (NASDAQ:TAYD) Downgraded by Wall Street Zen to Hold

Wall Street Zen cut shares of Taylor Devices from a "strong-buy" rating to a "hold" rating in a research report on Saturday...

Taylor Devices (NASDAQ:TAYD) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Taylor Devices (NASDAQ:TAYD - Get Free Report) released its earnings results on Tuesday. The industrial products company reported $0.79 EPS for the quarter, beating analysts' consensus estimates of $0.77 by $0.02. Taylor Devices had a return on equity of 15.75% and a net margin of 20.75%.The...

Taylor Devices Inc Q3 Profit Climbs

(RTTNews) - Taylor Devices Inc (TAYD) announced earnings for its third quarter that Increased, from last year...

TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH NINE-MONTH SALES

TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH NINE-MONTH SALES TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH NINE-MONTH...

Taylor Devices (NASDAQ:TAYD) Stock Crosses Above 200-Day Moving Average   - Here's Why

Taylor Devices (NASDAQ:TAYD) Shares Cross Above 200 Day Moving Average - Here's What Happened...

Taylor Devices, Inc. engages in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices. Its products include metal bellows dampers, fluid viscous dampers, landing and arresting gear, pumpkin mounts, isolation systems, custom applications, crane buffers, shock absorbers, liquid die springs, lock up devices, machined springs, and actuators. The company was founded by Paul H. Taylor on July 22, 1955 and is headquartered in North Tonawanda, NY.

Current Price	$51.00
Prev Close	$53.70
Open	$53.69
Dividend Yield	0.00%
50-Day Moving Average	$56.82
Beta	0.73
Avg. Volume	57,432.08
PE Ratio	16.12

52-Week High	$90.37
52-Week Low	$33.67
Market Capitalization	$164.17M
EPS (Annual)	$2.87
Price to Book	2.34
Revenue Per Employee	$337,903.10

TAYD
Taylor Devices Inc.

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest TAYD News

TAYDTaylor Devices Inc.